UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000933 |
|---|---|
| Receipt number | R000001116 |
| Scientific Title | Phase I clinical trial of WT1 peptide-based vaccine for the HLA-A*0201 positive patients with malignant tumors. |
| Date of disclosure of the study information | 2008/01/01 |
| Last modified on | 2011/06/09 13:57:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2007/12/05 21:41:22 | ||
| 2 | Update | 2007/12/09 03:47:04 | Condition Condition |
|
| 3 | Update | 2007/12/09 03:55:07 | Interventions/Control_1 Key inclusion criteria |
|
| 4 | Update | 2007/12/09 03:55:49 | Key exclusion criteria |
|
| 5 | Update | 2007/12/18 17:44:46 | Key inclusion criteria Key exclusion criteria |
|
| 6 | Update | 2009/05/24 20:50:35 | Public title Acronym |
|
| 7 | Update | 2009/05/24 20:51:27 | Type of intervention |
|
| 8 | Update | 2009/05/24 20:51:48 | Key secondary outcomes |
|
| 9 | Update | 2009/05/24 20:54:02 | Organization Organization Organization Organization Organization Organization |
|
| 10 | Update | 2010/06/21 18:07:08 | Recruitment status |
|
| 11 | Update | 2011/06/09 13:57:04 | Address |
|
| 12 | Update | 2011/06/09 13:57:45 | Recruitment status |
